Capital Research Global Investors 13D and 13G filings for Gilead Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 3:32 pm Sale | 2023-02-14 | 13G | GILEAD SCIENCES INC GILD | Capital Research Global Investors | 54,602,952 4.400% | -52,554,029![]() (-49.04%) | Filing |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | GILEAD SCIENCES INC GILD | Capital Research Global Investors | 107,156,981 8.500% | -14,515,418![]() (-11.93%) | Filing |
